BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 8759260)

  • 41. Threshold Static Automated Perimetry of the Full Visual Field in Idiopathic Intracranial Hypertension.
    Wall M; Subramani A; Chong LX; Galindo R; Turpin A; Kardon RH; Thurtell MJ; Bailey JA; Marin-Franch I
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1898-1905. PubMed ID: 31042797
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Idiopathic intracranial hypertension.
    Wall M
    Neurol Clin; 2010 Aug; 28(3):593-617. PubMed ID: 20637991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optic nerve sonography to monitor treatment efficacy in idiopathic intracranial hypertension: a case report.
    Lochner P; Nardone R; Tezzon F; Coppo L; Brigo F
    J Neuroimaging; 2013 Oct; 23(4):533-4. PubMed ID: 23320847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sonographic assessment of the optic nerve sheath diameter in the diagnosis of idiopathic intracranial hypertension.
    del Saz-Saucedo P; Redondo-González O; Mateu-Mateu Á; Huertas-Arroyo R; García-Ruiz R; Botia-Paniagua E
    J Neurol Sci; 2016 Feb; 361():122-7. PubMed ID: 26810528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant optic disk drusen and papilledema due to idiopathic intracranial hypertension in a pediatric cohort.
    Tavakoli M; Yan F; Tauscher R
    J AAPOS; 2024 Feb; 28(1):103806. PubMed ID: 38216114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension.
    Sinclair AJ; Burdon MA; Nightingale PG; Matthews TD; Jacks A; Lawden M; Sivaguru A; Gaskin BJ; Rauz S; Clarke CE; Ball AK
    J Neurol; 2012 Jul; 259(7):1406-12. PubMed ID: 22237821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
    Dinkin MJ; Patsalides A
    J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of eating disorders on idiopathic intracranial hypertension.
    Wallentin T; Linnet J; Lichtenstein MB; Hansen NS; Korsbæk JJ; Høgedal L; Hagen SM; Molander LD; Jensen RH; Beier D
    Cephalalgia; 2024 Mar; 44(3):3331024241237237. PubMed ID: 38459955
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optic nerve ultrasonography in monitoring treatment efficacy in pediatric idiopathic intracranial hypertension.
    Tekin Orgun L; Atalay HT; Arhan E; Aydın K; Serdaroglu A
    Childs Nerv Syst; 2020 Jul; 36(7):1425-1433. PubMed ID: 31940057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asymmetric papilledema in idiopathic intracranial hypertension.
    Bidot S; Bruce BB; Saindane AM; Newman NJ; Biousse V
    J Neuroophthalmol; 2015 Mar; 35(1):31-6. PubMed ID: 25494197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrospinal fluid dynamics between the intracranial and the subarachnoid space of the optic nerve. Is it always bidirectional?
    Killer HE; Jaggi GP; Flammer J; Miller NR; Huber AR; Mironov A
    Brain; 2007 Feb; 130(Pt 2):514-20. PubMed ID: 17114796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripapillary microperimetry for the diagnosis and follow-up of papilledema in cases treated for idiopathic intracranial hypertension.
    Elnahry GA; Elemary AM; Badr Eldin N; Nossair AA; Barrada OA; Elnahry AG
    Neurol Res; 2021 Jan; 43(1):61-70. PubMed ID: 32915708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudotumor cerebri: CT findings and correlation with vision loss.
    Gibby WA; Cohen MS; Goldberg HI; Sergott RC
    AJR Am J Roentgenol; 1993 Jan; 160(1):143-6. PubMed ID: 8416612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. False diagnosis of papilloedema and idiopathic intracranial hypertension.
    Mishra A; Mordekar SR; Rennie IG; Baxter PS
    Eur J Paediatr Neurol; 2007 Jan; 11(1):39-42. PubMed ID: 17185015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of tumor necrosis factor-alpha in the pathophysiology of idiopathic intracranial hypertension.
    Fahmy EM; Rashed LA; Mostafa RH; Ismail RS
    Acta Neurol Scand; 2021 Nov; 144(5):509-516. PubMed ID: 34131899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reevaluation of presentation and course of idiopathic intracranial hypertension--a large cohort comprehensive study.
    Pollak L; Zohar E; Glovinsky Y; Huna-Baron R
    Acta Neurol Scand; 2013 Jun; 127(6):406-12. PubMed ID: 23278763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of Optic Nerve Appearance on Visual Outcome in Pediatric Idiopathic Intracranial Hypertension.
    Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Newman NJ; Biousse V; Peragallo JH
    Can J Neurol Sci; 2020 Sep; 47(5):661-665. PubMed ID: 32362301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. B-Mode Transorbital Ultrasonography for the Diagnosis of Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis.
    Lochner P; Fassbender K; Knodel S; Andrejewski A; Lesmeister M; Wagenpfeil G; Nardone R; Brigo F
    Ultraschall Med; 2019 Apr; 40(2):247-252. PubMed ID: 30347420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MRI findings as markers of idiopathic intracranial hypertension.
    Barkatullah AF; Leishangthem L; Moss HE
    Curr Opin Neurol; 2021 Feb; 34(1):75-83. PubMed ID: 33230036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between idiopathic intracranial hypertension and obesity.
    Hannerz J; Ericson K
    Headache; 2009 Feb; 49(2):178-84. PubMed ID: 19222591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.